4.Selection of a Lead Molecule From Available Pool
4.Selection of a Lead Molecule From Available Pool
• The aim is to identify molecules that show high affinity and selectivity for
the target protein.
Hit Identification
• Once the screening is complete, the compounds that show promising
results are selected as hits.
• These hits are then subjected to further testing to determine their
potency, selectivity, and pharmacological properties. This process is
known as hit identification
Hit-to-Lead Optimization
• Hit-to-lead optimization is the process of selecting a hit molecule that
has the potential to become a lead molecule.
• Structure-activity relationship (SAR) is a fundamental concept in pharmaceutical sciences that explores the correlation between
the chemical structure of a compound and its biological activity. By systematically modifying the chemical structure of a compound
and assessing its activity, researchers can identify key structural features that influence its pharmacological effects. SAR studies
help in designing and optimizing drug candidates with improved potency, selectivity, and safety profiles, ultimately aiding in the
development of more effective medications.
• Pharmacophores are specific three-dimensional arrangements of atoms or functional groups within a molecule that are responsible for its biological activity by interacting with
complementary sites in a target biomolecule, such as a receptor or enzyme. These structural elements determine the molecule's pharmacological properties, including its affinity
and specificity for the target, as well as its mode of action. Pharmacophore mapping helps in drug design by identifying key features necessary for activity, guiding the
development of new compounds with optimized pharmacological profiles.
Steps need to be considered during
identification of a lead compound
1. Choosing the disease
Steps need to be considered during
identification of a lead compound
1. Choosing the disease
2. Choosing a drug target
Steps need to be considered during
identification of a lead compound
1. Choosing the disease
2. Choosing a drug target
3. Identifying a bioassay
Selectivity is Important!
HO
N NH2
F3C
HN
CH3 O
N N
H
H3C
serotonin prozac
Imipramine
(a classical tricyclic antidepressant)
Steps need to be considered during
identification of a lead compound
1. Choosing the disease
2. Choosing a drug target
3. Identifying a bioassay
• It is necessary to have a quick assay for the desired
biological activity and to be able to separate the
bioactive compound from the other inactive
substances
• Lastly, a structural determination will need to be
made
Simultaneously, Chemistry is Improving!